Mortgage Blog

The company said it cut between 5% and 6% of its workforce, which stood at 35,900 at the end of September. That would be a range of 1,795 to 2,154 employees who got the ax. But the impact could be far greater than the numbers suggest.

Seres Therapeutics Inc. is making big cuts to its workforce as it prioritizes the commercial launch of a treatment that received approval from the U.S. Food and Drug Administration earlier this year.

Energy Transfer said after the deal is has a presence “in all the major U.S. producing regions and markets across 41 states, further enhancing its leadership position in the midstream sector.”

Multiple billion-dollar deals were announced or closed in October, including ExxonMobil's announcement that it plans to buy Pioneer Natural Resources. So what do experts think this means for the sector, and who do they expect to be gobbled up next? Click through read more, and to check out a list of the biggest oil and gas drillers in North Texas.

“When we're considering a merger and acquisition, we are narrowly focused on the people and team that they have and the talent that exists,” Ben Wilson, Adams Brown managing partner and CEO, told the WBJ.

A number of companies are offering grant opportunities for businesses as 2023 draws near to a close.

Those grants come at a time when more business owners, squeezed by high interest rates and high costs, are turning to credit cards and relying on personal savings, according to a recent report by Intuit Quickbooks.

Because of that credit crunch, more businesses are turning to grants and alternatives to traditional business loans.

Here's a look at the business grants you can apply for in November…

Gilead advanced the money to Usama Malik for legal fees after he was charged with insider trading from his time as Immunomedics' CFO. Malik has been sentenced, and Gilead wants the money returned.

Nearly two years after coming out of retirement to fill a top executive leadership post at Kaleida Health, Cheryl Klass is retiring once again.

The Business Journals recently spoke with Cadrenal Therapeutics CEO Quang Pham about growing Florida's biosciences industry.

The latest move is a key step for an Alamo City company pursuing widespread adoption of its core technology.